Evidence map›Paper›PMID 35232999›Full record

ArticleScientific reports2022

Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction.

Koldo Garcia-Etxebarria, Olga Merino, Adrián Gaite-Reguero, Pedro M Rodrigues, Amaia Herrarte, Ane Etxart, David Ellinghaus, Horacio Alonso-Galan, Andre Franke, Urko M Marigorta and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Genetics of Inflammatory Bowel Disease.Molecular diagnosis & therapy · 2024
    Review
  14. Article
  15. Discovery of indole analogues fromFrontiers in pharmacology · 2023
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Koldo Garcia-EtxebarriaBiodonostia, Gastrointestinal Genetics Group, 20014, San Sebastián, Spain. koldo.garcia@biodonostia.org.
Olga MerinoGastroenterology Department, Hospital Universitario Cruces, Barakaldo, Spain.
Adrián Gaite-RegueroIntegrative Genomics Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Basque Country, Spain.
Pedro M RodriguesCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
Amaia HerrarteBiodonostia, Gastrointestinal Disease Group, Universidad del País Vasco (UPV/EHU), 20014, San Sebastián, Spain.
Ane EtxartBiodonostia, Gastrointestinal Disease Group, Universidad del País Vasco (UPV/EHU), 20014, San Sebastián, Spain.
David EllinghausInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Horacio Alonso-GalanBiodonostia, Gastrointestinal Disease Group, Universidad del País Vasco (UPV/EHU), 20014, San Sebastián, Spain.
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Urko M MarigortaIntegrative Genomics Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Basque Country, Spain.
Luis BujandaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
Mauro D'AmatoBiodonostia, Gastrointestinal Genetics Group, 20014, San Sebastián, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is characterised by chronic inflammation of the gastrointestinal tract. Although its aetiology remains unknown, environmental and genetic factors are involved in its development. Regarding genetics, more than 200 loci have been associated with IBD but the transferability of those signals to the Basque population living in Northern Spain, a population with distinctive genetic background, remains unknown. We have analysed 5,411,568 SNPs in 498 IBD cases and 935 controls from the Basque population. We found 33 suggestive loci (p < 5 × 10

Indexed as

Colitis, UlcerativeCrohn DiseaseFollistatin-Related ProteinsInflammatory Bowel DiseasesDNA-Binding ProteinsGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotideSpainBZW2 protein, humanDNA-Binding ProteinsFollistatin-Related ProteinsFSTL1 protein, human

Identifiers

PMID35232999
PMCPMC8888637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.